• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定 HDAC1 的天然抑制剂中的结构指纹,以加速癌症表观遗传学中的基于自然的药物发现。

Identification of structural fingerprints among natural inhibitors of HDAC1 to accelerate nature-inspired drug discovery in cancer epigenetics.

机构信息

Laboratory of Drug Design and Discovery, Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India.

Department of Biotechnology and Bioinformatics, School of Life Sciences, University of Hyderabad, Hyderabad, India.

出版信息

J Biomol Struct Dyn. 2024 Jul;42(11):5642-5656. doi: 10.1080/07391102.2023.2227710. Epub 2023 Jun 26.

DOI:10.1080/07391102.2023.2227710
PMID:38870352
Abstract

Histone deacetylase 1 (HDAC1), a class I HDAC enzyme, is crucial for histone modification. Currently, it is emerged as one of the important biological targets for designing small molecule drugs through cancer epigenetics. Along with synthetic inhibitors different natural inhibitors are showing potential HDAC1 inhibitions. In order to gain insights into the relationship between the molecular structures of the natural inhibitors and HDAC1, different molecular modelling techniques (Bayesian classification, recursive partitioning, molecular docking and molecular dynamics simulations) have been applied on a dataset of 155 HDAC1 nature-inspired inhibitors with diverse scaffolds. The Bayesian study showed acceptable values for both the training set and test sets. The Recursive partitioning study produced decision tree 1 with 6 leaves. Further, molecular docking study was processed for generating the protein ligand complex which identified some potential amino acid residues such as F205, H28, L271, P29, F150, Y204 for the binding interactions in case of natural inhibitors. Stability of these HDAC1-natutal inhibitors complexes has been also evaluated by molecular dynamics simulation study. The current modelling study is an attempt to get a deep insight into the different important structural fingerprints among different natural compounds modulating HDAC1 inhibition.Communicated by Ramaswamy H. Sarma.

摘要

组蛋白去乙酰化酶 1(HDAC1)是 I 类 HDAC 酶,对于组蛋白修饰至关重要。目前,它已成为通过癌症表观遗传学设计小分子药物的重要生物靶标之一。除了合成抑制剂外,不同的天然抑制剂也表现出对 HDAC1 的潜在抑制作用。为了深入了解天然抑制剂的分子结构与 HDAC1 之间的关系,我们应用了不同的分子建模技术(贝叶斯分类、递归分区、分子对接和分子动力学模拟),对具有不同支架的 155 种 HDAC1 天然抑制剂的数据集进行了分析。贝叶斯研究对训练集和测试集都显示出了可接受的值。递归分区研究生成了具有 6 个叶的决策树 1。此外,我们还进行了分子对接研究,生成了蛋白质-配体复合物,确定了一些潜在的氨基酸残基,如 F205、H28、L271、P29、F150、Y204,它们在天然抑制剂结合相互作用中发挥作用。我们还通过分子动力学模拟研究评估了这些 HDAC1-天然抑制剂复合物的稳定性。目前的建模研究旨在深入了解不同天然化合物调节 HDAC1 抑制作用的不同重要结构指纹。由 Ramaswamy H. Sarma 交流。

相似文献

1
Identification of structural fingerprints among natural inhibitors of HDAC1 to accelerate nature-inspired drug discovery in cancer epigenetics.鉴定 HDAC1 的天然抑制剂中的结构指纹,以加速癌症表观遗传学中的基于自然的药物发现。
J Biomol Struct Dyn. 2024 Jul;42(11):5642-5656. doi: 10.1080/07391102.2023.2227710. Epub 2023 Jun 26.
2
Insights into structural features of HDAC1 and its selectivity inhibition elucidated by Molecular dynamic simulation and Molecular Docking.通过分子动力学模拟和分子对接揭示 HDAC1 的结构特征及其选择性抑制作用的研究进展。
J Biomol Struct Dyn. 2019 Feb;37(3):584-610. doi: 10.1080/07391102.2018.1441072. Epub 2018 Mar 6.
3
Identification of Hydroxamic Acid Based Selective HDAC1 Inhibitors: Computer Aided Drug Design Studies.基于异羟肟酸的选择性HDAC1抑制剂的鉴定:计算机辅助药物设计研究
Curr Comput Aided Drug Des. 2019;15(2):145-166. doi: 10.2174/1573409914666180502113135.
4
Design, Synthesis, and Biological Evaluation of HDAC Inhibitors Containing Natural Product-Inspired -Linked 2-Acetylpyrrole Cap.含天然产物灵感连接的 2-乙酰基吡咯帽的 HDAC 抑制剂的设计、合成与生物评价。
Molecules. 2024 Sep 30;29(19):4653. doi: 10.3390/molecules29194653.
5
Fragment-Based Drug Design of Selective HDAC6 Inhibitors.选择性组蛋白去乙酰化酶6(HDAC6)抑制剂的基于片段的药物设计
Methods Mol Biol. 2021;2266:155-170. doi: 10.1007/978-1-0716-1209-5_9.
6
A mechanistic approach to explore novel HDAC1 inhibitor using pharmacophore modeling, 3D- QSAR analysis, molecular docking, density functional and molecular dynamics simulation study.一种利用药效团建模、3D-QSAR分析、分子对接、密度泛函和分子动力学模拟研究来探索新型HDAC1抑制剂的机制方法。
J Mol Graph Model. 2016 Nov;70:54-69. doi: 10.1016/j.jmgm.2016.09.008. Epub 2016 Sep 14.
7
Screening of Phytocompounds for Identification of Prospective Histone Deacetylase 1 (HDAC1) Inhibitor: An In Silico Molecular Docking, Molecular Dynamics Simulation, and MM-GBSA Approach.筛选植物化合物以鉴定潜在的组蛋白去乙酰化酶 1(HDAC1)抑制剂:一种基于分子对接、分子动力学模拟和 MM-GBSA 方法的研究。
Appl Biochem Biotechnol. 2024 Jul;196(7):3747-3764. doi: 10.1007/s12010-023-04731-3. Epub 2023 Sep 30.
8
Investigation on the isoform selectivity of histone deacetylase inhibitors using chemical feature based pharmacophore and docking approaches.基于化学特征药效团和对接方法研究组蛋白去乙酰化酶抑制剂的同工型选择性。
Eur J Med Chem. 2010 May;45(5):1777-91. doi: 10.1016/j.ejmech.2010.01.010. Epub 2010 Jan 28.
9
Discovering the binding modes of natural products with histone deacetylase 1.发现天然产物与组蛋白去乙酰化酶 1 的结合模式。
Med Chem. 2013 Feb;9(1):126-32. doi: 10.2174/157340613804488314.
10
Exploring structural requirements of HDAC10 inhibitors through comparative machine learning approaches.通过比较机器学习方法探索 HDAC10 抑制剂的结构要求。
J Mol Graph Model. 2023 Sep;123:108510. doi: 10.1016/j.jmgm.2023.108510. Epub 2023 May 16.

引用本文的文献

1
First report on exploration of structural features of natural compounds (NPACT database) for anti-breast cancer activity (MCF-7): QSAR-based virtual screening, molecular docking, ADMET, MD simulation, and DFT studies.关于天然化合物结构特征探索(NPACT数据库)用于抗乳腺癌活性(MCF-7)的首次报告:基于定量构效关系的虚拟筛选、分子对接、药物代谢动力学/药物毒性预测、分子动力学模拟和密度泛函理论研究。
In Silico Pharmacol. 2024 Oct 19;12(2):92. doi: 10.1007/s40203-024-00266-5. eCollection 2024.
2
Identification of structural features of surface modifiers in engineered nanostructured metal oxides regarding cell uptake through ML-based classification.基于机器学习的分类方法识别工程化纳米结构金属氧化物中表面改性剂的结构特征及其对细胞摄取的影响
Beilstein J Nanotechnol. 2024 Jul 22;15:909-924. doi: 10.3762/bjnano.15.75. eCollection 2024.